Relationship of Disease Progression and Plasma Histamine Concentrations in 11 Dogs with Mast Cell Tumors

Journal of Veterinary Internal Medicine

Volumn 17, Issue 2, 2003, Pages 194-198

  Ishiguro, Taketo ^a   Kadosawa, Tsuyoshi ^a   Takagi, Satoshi ^a   Kim, Gonhyung ^a   Ohsaki, Tomohiro ^a   Bosnakovski, Darko ^a   Okumura, Masahiro ^a   Fujinaga, Toru ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Gastrointestinal signs; Hyperhistaminemia; Mastocytoma

Indexed keywords

HISTAMINE;

ARTICLE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DOG; GASTROINTESTINAL TRACT; HISTAMINE BLOOD LEVEL; MAST CELL; MASTOCYTOMA; NONHUMAN; PROGNOSIS; ANIMAL; ANIMAL DISEASE; BLOOD; DOG DISEASE; FEMALE; MALE; PATHOLOGY; SARCOMA;

CANIS FAMILIARIS;

ANIMALS; DISEASE PROGRESSION; DOG DISEASES; DOGS; FEMALE; HISTAMINE; MALE; MAST-CELL SARCOMA;

EID: 0037980427     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2003)017<0194:RODPAP>2.3.CO;2     Document Type: Article

References (28)

1. Thamm DH, Vail DM. Mast cell tumors. In: Withrow SJ, MacEwen EG, eds. Small Animal Clinical Oncology, 3rd ed. Philadelphia, PA: WB Saunders; 2001:261-282.
2. O'Keefe DA. Canine mast cell tumors. Vet Clin North Am Small Anim Pract 1990;20:1105-1115.
3. Rogers KS. Mast cell tumors: Dilemmas of diagnosis and treatment. Vet Clin North Am Small Anim Pract 1996;26:87-102.
4. Patnaik AK, Ehler WJ, MacEwen EG. Canine cutaneous mast cell tumor: Morphologic grading and survival time in 83 dogs. Vet Pathol 1984;21:469-474.
5. Bostock DE. The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 1973;14:27-41.
6. Abadie JJ, Amardeilh MA, Delverdier ME. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J Am Vet Med Assoc 1999;215:1629-1634.
7. Seguin B, Leibman NF, Bregazzi VS, et al. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J Am Vet Med Assoc 2001;218:1120-1123.
8. Howard EB, Sawa TR, Nielsen SW, et al. Mastocytoma and gastroduodenal ulceration. Pathol Vet 1969;6:146-158.
9. Fox LE, Rosenthal RC, Twedt DC, et al. Plasma histamine and gastrin concentrations in 17 dogs with mast cell tumors. J Vet Intern Med 1990;4:242-246.
10. Dobson JM, Gorman NT. Cancer Chemotherapy in Small Animal Practice. Oxford, PA: Blackwell Scientific Publications; 1993:132-147.
11. Tams TR, Macy DW. Canine mast cell tumors. Compend Cont Educ Pract Vet 1981;3:869-878.
12. McCaw DL, Miller MA, Bergman PJ, et al. Vincristine therapy for mast cell tumors in dogs. J Vet Intern Med 1997;11:375-378.
13. Meleo KA. Tumors of the skin and associated structures. Vet Clin North Am Small Anim Pract 1997;27:73-94.
14. Morel AM, Delaage MA. Immunoanalysis of histamine through a novel chemical derivatization. J Allergy Clin Immunol 1988;82:646-654.
15. Zaki M, Harrington L, McCuen R, et al. Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum. Gastroenterology 1996;111:919-924.
16. Chrusch C, Sharma S, Unruh H, et al. Histamine H3 receptor blockade improves cardiac function in canine anaphylaxis. Am J Respir Crit Care Med 1999;160:1142-1149.
17. Harada M, Wada D, Kawasaki H, et al. Fundamental study on the determination of canine plasma histamine levels by radioimmunoassay. Nippon Shokakibyo Gakkai Zasshi 1990;87:2690.
18. Evans BD, Smith IE, Shorthouse AJ, et al. A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine. Br J Cancer 1982;45:466-468.
19. Church MK, Levi-Schaffer F. The human mast cell. J Allergy Clin Immunol 1997;99:155-160.
20. Bookbinder PF, Butt MT, Harvey HJ. Determination of the number of mast cells in lymph node, bone marrow, and buffy coat cytologic specimens from dogs. J Am Vet Med Assoc 1992;200:1648-1650.
21. McManus PM. Frequency and severity of mastocytemia in dogs with and without mast cell tumors: 120 cases (1995-1997). J Am Vet Med Assoc 1999;215:355-357.
22. Owen LN, ed. World Health Organization TNM Classification of Tumors in Domestic Animals, 1st ed. Geneva, Switzerland: World Health Organization; 1980:15-16.
23. Schubert ML, Shamburek RD. Control of acid secretion. Gastroenterol Clin North Am 1990;19:1-25.
24. Dy M, Machavoine F, Lebel B, et al. Interleukin 3 promotes histamine synthesis in hematopoietic progenitors by increasing histidine decarboxylase mRNA expression. Biochem Biophys Res Commun 1993;192:167-173.
25. Kawaguchi-Nagata K, Watanabe T, Yamatodani A, et al. In vitro increase of histidine decarboxylase activity and release of histamine by peritoneal resident cells of mast cell-deficient W/Wv mice; possible involvement of macrophages. J Biochem (Tokyo) 1988;103:24-30.
26. Takamatsu S, Nakashima I, Nakano K. Modulation of endotoxin-induced histamine synthesis by cytokines in mouse bone marrow-derived macrophages. J Immunol 1996;156:778-785.
27. Shiraishi M, Hirasawa N, Oikawa S, et al. Analysis of histamine-producing cells at the late phase of allergic inflammation in rats. Immunology 2000;99:600-606.
28. Endo Y, Nakamura M, Nitta Y, et al. Effects of macrophage depletion on the induction of histidine decarboxylase by lipopolysaccharide, interleukin 1 and tumour necrosis factor. Br J Pharmacol 1995;114:187-193.